224 related articles for article (PubMed ID: 21417506)
41. Characteristics, Quality and Contribution to Signal Detection of Spontaneous Reports of Adverse Drug Reactions Via the WEB-RADR Mobile Application: A Descriptive Cross-Sectional Study.
Oosterhuis I; Taavola H; Tregunno PM; Mas P; Gama S; Newbould V; Caster O; Härmark L
Drug Saf; 2018 Oct; 41(10):969-978. PubMed ID: 29761281
[TBL] [Abstract][Full Text] [Related]
42. Spontaneous reports of vasculitis as an adverse event following immunization: A descriptive analysis across three international databases.
Felicetti P; Trotta F; Bonetto C; Santuccio C; Brauchli Pernus Y; Burgner D; Chandler R; Girolomoni G; Hadden RD; Kochhar S; Kucuku M; Monaco G; Ozen S; Pahud B; Phuong L; Bachtiar NS; Teeba A; Top K; Varricchio F; Wise RP; Zanoni G; Živkovic S; Bonhoeffer J;
Vaccine; 2016 Dec; 34(51):6634-6640. PubMed ID: 26392009
[TBL] [Abstract][Full Text] [Related]
43. Analysis of Reports on Adverse Drug Reactions Related to Herbal Medicinal Products and Herbal Supplements in the Netherlands Received by the National Pharmacovigilance Centre Lareb.
van Hunsel FPAM; van der Kooi D; van de Koppel S; Kroes BH; Woerdenbag HJ
Drug Saf; 2022 Jun; 45(6):651-661. PubMed ID: 35608783
[TBL] [Abstract][Full Text] [Related]
44. Adverse events induced by ceftriaxone: a 10-year review of reported cases to Iranian Pharmacovigilance Centre.
Shalviri G; Yousefian S; Gholami K
J Clin Pharm Ther; 2012 Aug; 37(4):448-51. PubMed ID: 22122488
[TBL] [Abstract][Full Text] [Related]
45. [Adverse reactions to herbal remedies: analysis of reported adverse reactions in the Netherlands].
van Hunsel FP; van Grootheest AC
Ned Tijdschr Geneeskd; 2013; 157(47):A6615. PubMed ID: 24252407
[TBL] [Abstract][Full Text] [Related]
46. Rates of spontaneous reports of adverse drug reactions for drugs reported in children: a cross-sectional study with data from the Swedish adverse drug reaction database and the Swedish Prescribed Drug Register.
Wallerstedt SM; Brunlöf G; Sundström A
Drug Saf; 2011 Aug; 34(8):669-82. PubMed ID: 21751827
[TBL] [Abstract][Full Text] [Related]
47. Masking by vaccines in pediatric drug safety signal detection in the EudraVigilance database.
Dodd C; Pacurariu A; Osokogu OU; Weibel D; Ferrajolo C; Vo DH; Becker B; Kors JA; Sturkenboom M
Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1249-1256. PubMed ID: 30066460
[TBL] [Abstract][Full Text] [Related]
48. An analysis of the trends, characteristics, scope, and performance of the Zimbabwean pharmacovigilance reporting scheme.
Masuka JT; Khoza S
Pharmacol Res Perspect; 2020 Oct; 8(5):e00657. PubMed ID: 32930524
[TBL] [Abstract][Full Text] [Related]
49. Pediatric safety of tizanidine: clinical adverse event database and retrospective chart assessment.
Henney HR; Chez M
Paediatr Drugs; 2009; 11(6):397-406. PubMed ID: 19877725
[TBL] [Abstract][Full Text] [Related]
50. Adverse drug reactions in Ghanaian children: review of reports from 2000 to 2012 in VigiBase.
Cliff-Eribo KO; Choonara I; Dodoo A; Darko DM; Sammons H
Expert Opin Drug Saf; 2015; 14(12):1827-33. PubMed ID: 26436964
[TBL] [Abstract][Full Text] [Related]
51. Analysis of Hepatobiliary Disorder Reports Associated With the Use of Herbal Medicines in the Global Suspected ADR Database Vigibase.
van Hunsel F; van de Koppel S; Skalli S; Kuemmerle A; Teng L; Wang JB; Barnes J
Front Pharmacol; 2019; 10():1326. PubMed ID: 31780942
[No Abstract] [Full Text] [Related]
52. Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase®.
Ampadu HH; Hoekman J; de Bruin ML; Pal SN; Olsson S; Sartori D; Leufkens HG; Dodoo AN
Drug Saf; 2016 Apr; 39(4):335-45. PubMed ID: 26754924
[TBL] [Abstract][Full Text] [Related]
53. Drug interactions with apixaban: A systematic review of the literature and an analysis of VigiBase, the World Health Organization database of spontaneous safety reports.
Fernandez S; Lenoir C; Samer C; Rollason V
Pharmacol Res Perspect; 2020 Oct; 8(5):e00647. PubMed ID: 32881416
[TBL] [Abstract][Full Text] [Related]
54. Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase
Chandler RE; Juhlin K; Fransson J; Caster O; Edwards IR; Norén GN
Drug Saf; 2017 Jan; 40(1):81-90. PubMed ID: 27638661
[TBL] [Abstract][Full Text] [Related]
55. Vaccine-based subgroup analysis in VigiBase: effect on sensitivity in paediatric signal detection.
de Bie S; Verhamme KM; Straus SM; Stricker BH; Sturkenboom MC
Drug Saf; 2012 Apr; 35(4):335-46. PubMed ID: 22435344
[TBL] [Abstract][Full Text] [Related]
56. Performance assessment of the Thai National Center for Pharmacovigilance.
Kaewpanukrungsi W; Anantachoti P
Int J Risk Saf Med; 2015; 27(4):225-37. PubMed ID: 26756896
[TBL] [Abstract][Full Text] [Related]
57. A system for reporting and evaluating adverse drug reactions of herbal medicine in Taiwan from 1998 to 2016.
Chang HH; Chiang SY; Chen PC; Tsai CH; Yang RC; Tsai CL; Wu TH; Hsieh YW; Lin YC; Kuo YT; Chen KC; Chu HT
Sci Rep; 2021 Nov; 11(1):21476. PubMed ID: 34728662
[TBL] [Abstract][Full Text] [Related]
58. A comparison of patterns of spontaneous adverse drug reaction reporting with St. John's Wort and fluoxetine during the period 2000-2013.
Hoban CL; Byard RW; Musgrave IF
Clin Exp Pharmacol Physiol; 2015 Jul; 42(7):747-51. PubMed ID: 25988866
[TBL] [Abstract][Full Text] [Related]
59. Performance of probabilistic method to detect duplicate individual case safety reports.
Tregunno PM; Fink DB; Fernandez-Fernandez C; Lázaro-Bengoa E; Norén GN
Drug Saf; 2014 Apr; 37(4):249-58. PubMed ID: 24627310
[TBL] [Abstract][Full Text] [Related]
60. Impact of a New Consumer Form on the Quantity and Quality of Adverse Event Reports Submitted to the United States Food and Drug Administration.
Muñoz MA; Delcher C; Dal Pan GJ; Kortepeter CM; Wu E; Wei YJ; Xiao H; Winterstein AG
Pharmacotherapy; 2019 Nov; 39(11):1042-1052. PubMed ID: 31479525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
